www.fdanews.com/articles/195754-drawbridge-healths-hemoglobin-a1c-test-certified-in-europe
![DrawbridgeHealth_Logo.png](https://www.fdanews.com/ext/resources/test/Device_Images6/DrawbridgeHealth_Logo.png?t=1580860050&width=430)
Drawbridge Health’s Hemoglobin A1C Test Certified in Europe
February 4, 2020
DrawBridge Health has earned the CE Mark for its OneDraw test system, a device that collects blood samples from the upper arm for hemoglobin A1C testing without the need for a traditional hypodermic needle.
The device is placed on the patient’s skin and draws blood using tiny lancets and vacuum suction, doing away with the need to puncture a patient’s vein with a needle. The sample is stored in a removable cartridge and plastic cassette that can be shipped to a laboratory for testing.
The company plans to launch the device in Europe this year. It previously received FDA 510(k) clearance.